Bio-Techne
Highly Engaged Employees
Business Services · Minnesota, United States · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
614 Mckinley Pl NE, Minneapolis, Minneso...Phone Number
(612) 379-2956Website
www.bio-techne.comRevenue
$1.2 BillionStock Symbol
TECHIndustry
About Bio-Techne
Bio-Techne Org Chart
Is Bio-Techne your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Bio-Techne, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Bio-Techne recently announced quarterly report
Funding: Get notified immidiatlly once Bio-Techne has new funding data
Congratulate Masked Content for being promoted to Masked Content at Bio-Techne
Check out if Bio-Techne is spiking on competitors!
Click to see if Bio-Techne had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Bio-Techne has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Bio-Techne launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Bio-Techne
Compare insights from companies similar to Bio-Techne, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Bio-Techne
Company Profile Activity
Activity Insights
Bio-Techne is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Bio-Techne is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Bio-Techne.
Bio-Techne Tech Stack
A closer look at the technologies used by Bio-Techne
Most Recent Scoops
Bio-Techne News & Media
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: LCI Industries (NYSE – LCII), Iridium Communications Inc. (Nasdaq – IRDM), Bio-Techne Corporation (Nasdaq – TECH), Arcosa, Inc. (NYSE – ACA)
BALA CYNWYD, Pa., July 06, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Bio-Techne Corporation (NASDAQ: TECH)
NEW YORK, June 26, 2026 /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2025 ISS Securities Class Action Services Report. The...Bio-Techne Corporation (TECH) M&A Call Transcript
Bio-Techne Corporation (TECH) M&A Call June 25, 2026 8:00 AM EDTCompany ParticipantsFlorian Schraeder - Head of Investor RelationsKai Beckmann - CEO...S&C Advises Merck KGaA on $11.3 Billion Acquisition of Bio-Techne
Longtime Sullivan & Cromwell client Merck KGaA has agreed to acquire Minneapolis-based Bio-Techne, a global provider of life science tools, analytical technologies and consumables, for an enterprise value of $11.3 billion, marking Merck KGaA’s largest acquisition in more than a decade.
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Bio-Techne
Founded in 1981, Bio-Techne Corporation is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and prov... Read More
